Clinical Trials Directory

Trials / Completed

CompletedNCT02471664

Mitral Loop Cerclage(MLC) for Reducing Functional Mitral Regurgitation

The Study on Safety and Feasibility of Mitral Loop Cerclage(MLC) Annuloplasty Procedure With Investigational Medical Device (MLC-B-45-75-R and Other 11 Models) : Single-centre, Open Label, Single Arm, Feasibility Test

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
5 (actual)
Sponsor
Tau-MEDICAL Co., Ltd. · Industry
Sex
All
Age
20 Years – 85 Years
Healthy volunteers
Not accepted

Summary

To evaluate safety and feasibility of Mitral Loop Cerclage(MLC) Annuloplasty with CSTV for repair of functional mitral regurgitation.

Detailed description

The objective of this prospective, single-center, open label, feasibility test is to assess the safety and efficacy of Mitral Loop Cerclage Annuloplasty with CSTV protective device in treating functional mitral regurgitation (FMR) associated with heart failure.

Conditions

Interventions

TypeNameDescription
DEVICEMitral Loop Cerclage Annuloplasty

Timeline

Start date
2015-07-01
Primary completion
2016-03-01
Completion
2016-07-01
First posted
2015-06-15
Last updated
2017-10-13

Locations

2 sites across 2 countries: United States, South Korea

Source: ClinicalTrials.gov record NCT02471664. Inclusion in this directory is not an endorsement.

Mitral Loop Cerclage(MLC) for Reducing Functional Mitral Regurgitation (NCT02471664) · Clinical Trials Directory